Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Journal of Theoretical Biology
|
September 3, 2018
Methods for determining key components in a mathematical model for tumor-immune dynamics in multiple myeloma
Jill Gallaher, Kamila Larripa, Marissa Renardy, et al.
Journal of Neurosurgery
|
November 24, 2006
Does dose rate affect efficacy? The outcomes of 256 gamma knife surgery procedures for trigeminal neuralgia and other types of facial pain as they relate to the half-life of cobalt
Christopher J Balamucki, Volker W Stieber, Thomas L Ellis, et al.
The New England Journal of Medicine
|
November 8, 2018
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
Meletios A Dimopoulos, Dominik Dytfeld, Sebastian Grosicki, et al.
Blood
|
April 20, 2016
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM
Andrzej Jakubowiak, Massimo Offidani, Brigitte Pégourie, et al.
Rand Health Quarterly
|
June 18, 2019
Evaluation of the Strength Aptitude Test and Other Fitness Tests to Qualify Air Force Recruits for Physically Demanding Specialties
Sean Robson, Stephanie Pezard, Maria C Lytell, et al.
Haematologica
|
May 20, 2021
Myeloma natural killer cells are exhausted and have impaired regulation of activation
Criselle D'Souza, Simon P Keam, Han Xian Aw Yeang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2010
Heterocyclic acetamide and benzamide derivatives as potent and selective beta3-adrenergic receptor agonists with improved rodent pharmacokinetic profiles
Stephen D Goble, Liping Wang, K Lulu Howell, et al.
Haematologica
|
June 30, 2022
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells
Kelden Richardson, Simon P Keam, Joe Jiang Zhu, et al.
Pediatrics
|
March 17, 2010
Clinical genetic testing for patients with autism spectrum disorders
Yiping Shen, Kira A Dies, Ingrid A Holm, et al.
Annals of Neurology
|
May 10, 2014
Copy number variation plays an important role in clinical epilepsy
Heather Olson, Yiping Shen, Jennifer Avallone, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Journal of Theoretical Biology
|
September 3, 2018
Methods for determining key components in a mathematical model for tumor-immune dynamics in multiple myeloma
Jill Gallaher, Kamila Larripa, Marissa Renardy, et al.
Journal of Neurosurgery
|
November 24, 2006
Does dose rate affect efficacy? The outcomes of 256 gamma knife surgery procedures for trigeminal neuralgia and other types of facial pain as they relate to the half-life of cobalt
Christopher J Balamucki, Volker W Stieber, Thomas L Ellis, et al.
The New England Journal of Medicine
|
November 8, 2018
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
Meletios A Dimopoulos, Dominik Dytfeld, Sebastian Grosicki, et al.
Blood
|
April 20, 2016
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM
Andrzej Jakubowiak, Massimo Offidani, Brigitte Pégourie, et al.
Rand Health Quarterly
|
June 18, 2019
Evaluation of the Strength Aptitude Test and Other Fitness Tests to Qualify Air Force Recruits for Physically Demanding Specialties
Sean Robson, Stephanie Pezard, Maria C Lytell, et al.
Haematologica
|
May 20, 2021
Myeloma natural killer cells are exhausted and have impaired regulation of activation
Criselle D'Souza, Simon P Keam, Han Xian Aw Yeang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2010
Heterocyclic acetamide and benzamide derivatives as potent and selective beta3-adrenergic receptor agonists with improved rodent pharmacokinetic profiles
Stephen D Goble, Liping Wang, K Lulu Howell, et al.
Haematologica
|
June 30, 2022
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells
Kelden Richardson, Simon P Keam, Joe Jiang Zhu, et al.
Pediatrics
|
March 17, 2010
Clinical genetic testing for patients with autism spectrum disorders
Yiping Shen, Kira A Dies, Ingrid A Holm, et al.
Annals of Neurology
|
May 10, 2014
Copy number variation plays an important role in clinical epilepsy
Heather Olson, Yiping Shen, Jennifer Avallone, et al.
Page
of 5